Gyros - Immunogenicity (ADA) assay, Anti drug antibody, Drug tolerance, Unwanted immune response

Posters and presentations using Gyrolab ADA solution

Development of an automated ADA immunoassay with integrated acid dissociation and neutralization

A. Eckersten et al., Gyros AB, EBF 2011 4th Open Symposium

(PDF, 926.8 kB)

Immunogenicity monitoring during preclinical development of Nanobodies®: comparing assay formats and species matrices

S. Poelmans et al., Ablynx NV, AAPS National Biotechnology Conference, San Francisco, 2010

(PDF, 2.0 MB)

Utility of the Gyros Gyrolab in Research and DMPK - An Automated Ligand Binding Assay Platform

K. Brady, Pfizer UK, Sixth Annual PEGS Summit, Boston, 2010

(PDF, 587.9 kB)

Application of the Gyrolab™ platform to ligand-binding assays: a user’s perspective

J. Mora et al., Bioanalysis, Volume 2, Issue 10, pages 1711-1715, October 2010

A novel strategy to reduce the immunogenicity of biological therapies

J. Somerfield et al., The Journal of Immunology, Volume 185, no. 1, pages 763-768, July 2010

Gyrolab ADA Solution

(PDF, 1.4 MB)

Gyrolab Bioaffy CDs and Rexxip buffers

(PDF, 843.9 kB)

Gyrolab xP workstation

(PDF, 827.8 kB)